Wolverine Trading
AVEO

Wolverine Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Wolverine Trading’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,385
Closed -$10.3K – 5345
2019
Q2 		$9K Buy
+1,385
New +$11.9K ﹤0.01% 4315
2019
Q1 		– Sell
-11,875
Closed -$194K – 5658
2018
Q4 		$194K Buy
11,875
+7,028
+145% +$155K ﹤0.01% 3715
2018
Q3 		$160K Buy
4,847
+1,075
+28% +$27.6K ﹤0.01% 4364
2018
Q2 		$109K Hold
3,772
– – ﹤0.01% 4695
2018
Q1 		$109K Buy
+3,772
New +$110K ﹤0.01% 4695
2017
Q4 		– Sell
-5,431
Closed -$198K – 5797
2017
Q3 		$198K Buy
5,431
+3,899
+255% +$121K ﹤0.01% 3824
2017
Q2 		$33K Buy
+1,532
New +$12.1K ﹤0.01% 4113
2016
Q4 		– Sell
-1,200
Closed -$11K – 5484
2016
Q3 		$11K Buy
+1,200
New +$11.3K ﹤0.01% 4533

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wolverine Trading's AVEO Position: Q3 2019 in Review

Wolverine Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 1,385 shares — an estimated $10.3K sold.

Wolverine Trading first reported a position in AVEO in Q3 2016 and held it in 8 quarters. The position peaked at $198K in Q3 2017. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

  • Wolverine Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 1,385 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $10.3K.
  • Wolverine Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2016 and held it in 8 quarters.
  • Wolverine Trading's AVEO Pharmaceuticals, Inc. position peaked at $198K in Q3 2017.
  • 59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.